We’re excited to announce that we’ve just published a whitepaper that represents a substantial advance in parents’ ability to screen their embryos for a wide variety of diseases.
However, if an age cut off was chosen, say diagnosed by age 70, this will work very well. Which hopefully what was done in the models.
The first paper also contains a good, and rarely stated realization, on interplay of PGS and age for late-onset diseases. Largely it is consilient with your criticism of the competitors.
An excellent post/paper. Congratulations with the exit from the stealth mode and the commercial launch!
One quibble is the threshold model as applied to late-onset diseases.
See: https://peerj.com/articles/7168/ and some of the https://www.mdpi.com/1422-0067/20/20/5013
However, if an age cut off was chosen, say diagnosed by age 70, this will work very well. Which hopefully what was done in the models.
The first paper also contains a good, and rarely stated realization, on interplay of PGS and age for late-onset diseases. Largely it is consilient with your criticism of the competitors.